Dev Information Technology Ltd
Disclosure under Regulation 30 read with Schedule III Part A for sale/transfer of company''s product on slump sale basis
M&A
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 31 Mar 2026, 09:17 PM IST · BSE ID: ad3275ba-54e5-4e58-85fa-4b3c06777802
View Original BSE Filing (PDF)
💡
In Simple Terms
Dev IT sold two of its software products to a related company for Rs. 11.90 Crores, completing the deal on March 31, 2026.
🤖 AI Summary
- Board approved slump sale of ByteSIGNER and Talligence products to Byte Technosys Private Limited for Rs. 11.90 Crores
- Products generated Rs. 3.97 lakhs revenue in FY 2024-25, representing 0.021% of consolidated turnover
- Net asset value of divested products approximately Rs. 8.75 crores, constituting 12.74% of company net worth FY 2024-25
- Buyer is associate company with immediate director relatives as shareholders; transaction conducted at arm's length basis
- Transaction closing expected on or before September 30, 2026; independent valuer assessment conducted
🔢 Key Numbers — exact figures from BSE filing, not rounded
Slump sale consideration
Rs. 11.90 Crores
FY 2024-25 revenue from products sold
Rs. 3.97 lakhs
Revenue as % of consolidated turnover FY 2024-25
0.021%
Net asset value of divested products (approx.)
Rs. 8.75 crores
Divested NAV as % of company net worth FY 2024-25
12.74%
Transaction agreement date
March 31, 2026
Expected closing date
On or before September 30, 2026
🏢 How This Affects the Company
Company exits ByteSIGNER and Talligence product lines, which contributed minimal revenue (Rs. 3.97 lakhs or 0.021% of FY 2024-25 turnover). Divestment represents portfolio rationalization of non-core or underperforming assets.
Cash inflow of Rs. 11.90 Crores expected by September 30, 2026. Removal of Rs. 8.75 crores net asset value (12.74% of company net worth) from balance sheet will reduce reported net worth unless proceeds are reinvested or retained as cash.
Related-party transaction with director relatives involved in buyer company. Although valuation by independent registered valuer and board/audit committee approval mitigate governance risk, concentration of sale proceeds deployment decisions on management becomes material.
👥 What This Means For Shareholders
✅
Action Required
No action required. Board and audit committee have approved transaction under regulatory requirements. Closing expected September 30, 2026.
👤
Who Is Affected
All shareholders equally affected. Divested assets represented 12.74% of company net worth (Rs. 8.75 crores). Buyer's director relatives create indirect related-party interest. Cash inflow of Rs. 11.90 Crores benefits balance sheet.
🔍
Management Signal
Management prioritizes portfolio focus by exiting non-core, low-return product lines. Sale to associate company suggests strategic repositioning rather than distressed exit.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Transaction closing confirmation filing — watch for Reg 30 completion disclosure by September 30, 2026
Q1 FY27 results — verify Rs. 11.90 Crores cash receipt recorded and capital deployment clarity provided
Board decision on capital deployment — monitor for dividend, investment, or debt reduction announcements post-closing
MEDIUM RISK
Related-party transaction with director relatives involved in buyer. Independent valuation mitigates pricing risk, but capital redeployment by management requires shareholder monitoring.
💡 Investor Takeaway
Dev IT divested two low-revenue products (Rs. 3.97 lakhs FY25 revenue) with Rs. 8.75 crores net asset value for Rs. 11.90 Crores cash. Related-party transaction approved at arm's length by independent valuer. Closing expected September 30, 2026. Watch capital redeployment post-closing.
⚖️ Strengths & Concerns
✅ Positives
- Independent valuation conducted and arm's length pricing confirmed by board and audit committee review
- Asset divestment removes 12.74% of net worth tied to low-revenue products, freeing capital for higher-return deployment
⚠️ Concerns
- Transaction with related party — buyer is associate company with director relatives; potential for capital deployment bias post-sale
- Closing timeline extends to September 30, 2026; cash flow benefit delayed six months from agreement date